In National Advertising Division Challenge, Lunavia Voluntarily Discontinues Product Claims for its Nail Fungus Treatment
New York, NY, October 15, 2025 - BBB National Programs’ National Advertising Division reviewed a challenge brought by Advantice Health regarding express claims made by XF Agencija, d/b/a Lunavia. The challenge pertained to claims appearing on Lunavia’s website, social media, and third-party retailer pages regarding the benefits and efficacy of its antifungal nail pen.
During the inquiry, Lunavia informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.
During the inquiry, Lunavia informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.